» Authors » Masakatsu Motomura

Masakatsu Motomura

Explore the profile of Masakatsu Motomura including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 97
Citations 1043
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Motomura M, Kitanosono H, Yoshimura S, Shiraishi H
Brain Nerve . 2024 May; 76(5):623-629. PMID: 38741505
Reportedly, patients with muscle-specific kinase (MuSK) antibody-positive myasthenia gravis (MG) account for approximately 3.0% of all patients with MG in Japan. Compared with patients who have acetylcholine receptor antibody-positive MG,...
2.
Kitanosono H, Yoshimura S, Shiraishi H, Motomura M
Brain Nerve . 2024 Jan; 76(1):33-40. PMID: 38191137
Approximately 90% of patients with Lambert-Eaton myasthenic syndrome (LEMS) show positive P/Q-type voltage-gated calcium channels antibodies, which can be broadly classified clinically as paraneoplastic, particularly with small cell lung carcinoma...
3.
Motomura M, Irioka T
Brain Nerve . 2023 Jul; 75(7):837-845. PMID: 37431074
Approximately 90% of patients with Lambert-Eaton myasthenic syndrome (LEMS) are positive for P/Q-type voltage-gated calcium channels (VGCCs) antibodies, and can be broadly divided into two groups: paraneoplastic, especially with small...
4.
Nagaoka A, Tsujino A, Shiraishi H, Kanamoto T, Shima T, Yoshimura S, et al.
J Neurol Sci . 2022 Nov; 443:120494. PMID: 36403297
This study aimed to evaluate the diagnostic usefulness of motor end-plate (MEP) analysis along with clustered acetylcholine receptor (AChR) antibody (Ab) assays in patients with myasthenia-like symptoms but negative routine...
5.
Winklehner M, Bauer J, Endmayr V, Schwaiger C, Ricken G, Motomura M, et al.
Neurol Neuroimmunol Neuroinflamm . 2022 Sep; 9(4). PMID: 36070310
Background And Objectives: Paraneoplastic cerebellar degeneration (PCD) is characterized by a widespread loss of Purkinje cells (PCs) and may be associated with autoantibodies against intracellular antigens such as Yo or...
6.
Yamasaki H, Futamura N, Funakawa I, Kohara N, Yoshimura S, Motomura M
Intern Med . 2021 Sep; 61(7):1063-1065. PMID: 34544947
We herein report two P/Q-type voltage-gated calcium channel (VGCC) antibody-positive Lambert-Eaton myasthenic syndrome (LEMS) patients who responded dramatically to cholinesterase inhibitors. Patient 1, a 76-year-old man, had small-cell lung cancer...
7.
Ikeda K, Hirose B, Yamamoto D, Hisahara S, Shimohama S, Shiraishi H, et al.
Muscle Nerve . 2020 Dec; 63(3):E16-E18. PMID: 33290573
No abstract available.
8.
Akaishi T, Motomura M, Aoki M, Utsugisawa K
Ann Transl Med . 2019 Oct; 7(Suppl 6):S208. PMID: 31656787
No abstract available.
9.
Akaishi T, Motomura M, Shiraishi H, Yoshimura S, Abe M, Ishii T, et al.
J Neurol Sci . 2019 Oct; 407:116530. PMID: 31654832
Introduction: Myasthenic crisis (MC) is a life-threatening condition in patients with myasthenia gravis (MG), for which thymectomy is known to be a predisposing factor. There are many preoperative factors that...
10.
Shimizu F, Takeshita Y, Sano Y, Hamamoto Y, Shiraishi H, Sato T, et al.
Brain . 2019 Jun; 142(8):2253-2264. PMID: 31236596
Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disease of the neuromuscular junction caused by autoantibodies binding to P/Q-type voltage-gated calcium channels. Breakdown of the blood-brain barrier and diffusion of cerebellar...